Loading…

AJAP1 affects behavioral changes and GABABR1 level in epileptic mice

Adherens junction-associated protein-1 (AJAP1), also called SHREW1, was first discovered as a novel component of adherens junctions in 2004. In later studies, AJAP1 was found to suppress invasion and predict recurrence of some tumors. Apart from its function as a putative tumor suppressor, AJAP1 is...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2020-04, Vol.524 (4), p.1057-1063
Main Authors: Zhang, Mingli, Zhou, Xueying, Jiang, Wei, Li, Min, Zhou, Ruijiao, Zhou, Shengnian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043
cites cdi_FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043
container_end_page 1063
container_issue 4
container_start_page 1057
container_title Biochemical and biophysical research communications
container_volume 524
creator Zhang, Mingli
Zhou, Xueying
Jiang, Wei
Li, Min
Zhou, Ruijiao
Zhou, Shengnian
description Adherens junction-associated protein-1 (AJAP1), also called SHREW1, was first discovered as a novel component of adherens junctions in 2004. In later studies, AJAP1 was found to suppress invasion and predict recurrence of some tumors. Apart from its function as a putative tumor suppressor, AJAP1 is still poorly understood. Schwenk et al. recently found that AJAP1 was tightly associated with the γ-Aminobutyric acid type B receptor subunit 1(GABABR1). It is well known that GABABR plays a vital role in epilepsy as an inhibitory transmitter receptor. Structurally adjacent, possibly functionally interacting, therefore, we hypothesize that AJAP1 participates in the onset and progression of epilepsy. We designed this experiment to investigate the expression and location of AJAP1 in temporal lobe epilepsy (TLE) patients and kainic acid(KA)-induced epilepsy animal models by immunofluorescence and Western blot analyses. We overexpressed and inhibited AJAP1 through lentiviruses in KA-induced models and observed the corresponding effects on epileptic animals. Double-label immunofluorescence showed that AJAP1 was expressed mainly in neurons. Western blot analysis revealed that AJAP1 expression was downregulated in the neocortex of TLE patients and the hippocampus and neocortex of epileptic animal models. The overexpression of AJAP1 can reduce the frequency of spontaneous seizures, whereas the inhibition of AJAP1 expression can increase the incidence rate. Our study demonstrated that AJAP1 may be involved in the pathogenic process of epilepsy and may represent a novel antiepileptic target. •Our study confirms that AJAP1 is closely related to epilepsy.•The expression of AJAP1 decreased in epileptic patients and animal models.•We have recorded the behavioral changes in epileptic mice with different levels of AJAP1.•We found that epilepsy was negatively correlated with the level of AJAP1.•In epileptic mice, different expression of AJAP1 affects the levels of GABABR1.
doi_str_mv 10.1016/j.bbrc.2020.02.036
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2357471434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X20303028</els_id><sourcerecordid>2357471434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043</originalsourceid><addsrcrecordid>eNp9kEFLwzAYhoMoOKd_wFOOXlq_pGlqwEs3dSoDRRS8hST96jK6tibdwH_vyjx7ei_v88L7EHLJIGXA5PU6tTa4lAOHFHgKmTwiEwYKEs5AHJMJAMiEK_Z5Ss5iXAMwJqSakLvyuXxl1NQ1uiFSiyuz810wDXUr035hpKat6KKclbM3RhvcYUN9S7H3DfaDd3TjHZ6Tk9o0ES_-cko-Hu7f54_J8mXxNC-XicuybEh4hVwggLBZDkV9oxQKp5Qr6lzxghkmrARuWZWDlSJHp4RzNpd5Lk1Vg8im5Oqw24fue4tx0BsfHTaNabHbRs2zvBAFE9lY5YeqC12MAWvdB78x4Ucz0KMyvdajMj0q08D1Xtkeuj1AuD-x8xh0dB5bh5UPez266vx_-C8XPnIZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2357471434</pqid></control><display><type>article</type><title>AJAP1 affects behavioral changes and GABABR1 level in epileptic mice</title><source>ScienceDirect Freedom Collection</source><creator>Zhang, Mingli ; Zhou, Xueying ; Jiang, Wei ; Li, Min ; Zhou, Ruijiao ; Zhou, Shengnian</creator><creatorcontrib>Zhang, Mingli ; Zhou, Xueying ; Jiang, Wei ; Li, Min ; Zhou, Ruijiao ; Zhou, Shengnian</creatorcontrib><description>Adherens junction-associated protein-1 (AJAP1), also called SHREW1, was first discovered as a novel component of adherens junctions in 2004. In later studies, AJAP1 was found to suppress invasion and predict recurrence of some tumors. Apart from its function as a putative tumor suppressor, AJAP1 is still poorly understood. Schwenk et al. recently found that AJAP1 was tightly associated with the γ-Aminobutyric acid type B receptor subunit 1(GABABR1). It is well known that GABABR plays a vital role in epilepsy as an inhibitory transmitter receptor. Structurally adjacent, possibly functionally interacting, therefore, we hypothesize that AJAP1 participates in the onset and progression of epilepsy. We designed this experiment to investigate the expression and location of AJAP1 in temporal lobe epilepsy (TLE) patients and kainic acid(KA)-induced epilepsy animal models by immunofluorescence and Western blot analyses. We overexpressed and inhibited AJAP1 through lentiviruses in KA-induced models and observed the corresponding effects on epileptic animals. Double-label immunofluorescence showed that AJAP1 was expressed mainly in neurons. Western blot analysis revealed that AJAP1 expression was downregulated in the neocortex of TLE patients and the hippocampus and neocortex of epileptic animal models. The overexpression of AJAP1 can reduce the frequency of spontaneous seizures, whereas the inhibition of AJAP1 expression can increase the incidence rate. Our study demonstrated that AJAP1 may be involved in the pathogenic process of epilepsy and may represent a novel antiepileptic target. •Our study confirms that AJAP1 is closely related to epilepsy.•The expression of AJAP1 decreased in epileptic patients and animal models.•We have recorded the behavioral changes in epileptic mice with different levels of AJAP1.•We found that epilepsy was negatively correlated with the level of AJAP1.•In epileptic mice, different expression of AJAP1 affects the levels of GABABR1.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2020.02.036</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>AJAP1 ; Epilepsy ; GABABR1 ; Lentivirus ; Therapeutic target</subject><ispartof>Biochemical and biophysical research communications, 2020-04, Vol.524 (4), p.1057-1063</ispartof><rights>2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043</citedby><cites>FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Zhang, Mingli</creatorcontrib><creatorcontrib>Zhou, Xueying</creatorcontrib><creatorcontrib>Jiang, Wei</creatorcontrib><creatorcontrib>Li, Min</creatorcontrib><creatorcontrib>Zhou, Ruijiao</creatorcontrib><creatorcontrib>Zhou, Shengnian</creatorcontrib><title>AJAP1 affects behavioral changes and GABABR1 level in epileptic mice</title><title>Biochemical and biophysical research communications</title><description>Adherens junction-associated protein-1 (AJAP1), also called SHREW1, was first discovered as a novel component of adherens junctions in 2004. In later studies, AJAP1 was found to suppress invasion and predict recurrence of some tumors. Apart from its function as a putative tumor suppressor, AJAP1 is still poorly understood. Schwenk et al. recently found that AJAP1 was tightly associated with the γ-Aminobutyric acid type B receptor subunit 1(GABABR1). It is well known that GABABR plays a vital role in epilepsy as an inhibitory transmitter receptor. Structurally adjacent, possibly functionally interacting, therefore, we hypothesize that AJAP1 participates in the onset and progression of epilepsy. We designed this experiment to investigate the expression and location of AJAP1 in temporal lobe epilepsy (TLE) patients and kainic acid(KA)-induced epilepsy animal models by immunofluorescence and Western blot analyses. We overexpressed and inhibited AJAP1 through lentiviruses in KA-induced models and observed the corresponding effects on epileptic animals. Double-label immunofluorescence showed that AJAP1 was expressed mainly in neurons. Western blot analysis revealed that AJAP1 expression was downregulated in the neocortex of TLE patients and the hippocampus and neocortex of epileptic animal models. The overexpression of AJAP1 can reduce the frequency of spontaneous seizures, whereas the inhibition of AJAP1 expression can increase the incidence rate. Our study demonstrated that AJAP1 may be involved in the pathogenic process of epilepsy and may represent a novel antiepileptic target. •Our study confirms that AJAP1 is closely related to epilepsy.•The expression of AJAP1 decreased in epileptic patients and animal models.•We have recorded the behavioral changes in epileptic mice with different levels of AJAP1.•We found that epilepsy was negatively correlated with the level of AJAP1.•In epileptic mice, different expression of AJAP1 affects the levels of GABABR1.</description><subject>AJAP1</subject><subject>Epilepsy</subject><subject>GABABR1</subject><subject>Lentivirus</subject><subject>Therapeutic target</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAYhoMoOKd_wFOOXlq_pGlqwEs3dSoDRRS8hST96jK6tibdwH_vyjx7ei_v88L7EHLJIGXA5PU6tTa4lAOHFHgKmTwiEwYKEs5AHJMJAMiEK_Z5Ss5iXAMwJqSakLvyuXxl1NQ1uiFSiyuz810wDXUr035hpKat6KKclbM3RhvcYUN9S7H3DfaDd3TjHZ6Tk9o0ES_-cko-Hu7f54_J8mXxNC-XicuybEh4hVwggLBZDkV9oxQKp5Qr6lzxghkmrARuWZWDlSJHp4RzNpd5Lk1Vg8im5Oqw24fue4tx0BsfHTaNabHbRs2zvBAFE9lY5YeqC12MAWvdB78x4Ucz0KMyvdajMj0q08D1Xtkeuj1AuD-x8xh0dB5bh5UPez266vx_-C8XPnIZ</recordid><startdate>20200416</startdate><enddate>20200416</enddate><creator>Zhang, Mingli</creator><creator>Zhou, Xueying</creator><creator>Jiang, Wei</creator><creator>Li, Min</creator><creator>Zhou, Ruijiao</creator><creator>Zhou, Shengnian</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200416</creationdate><title>AJAP1 affects behavioral changes and GABABR1 level in epileptic mice</title><author>Zhang, Mingli ; Zhou, Xueying ; Jiang, Wei ; Li, Min ; Zhou, Ruijiao ; Zhou, Shengnian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AJAP1</topic><topic>Epilepsy</topic><topic>GABABR1</topic><topic>Lentivirus</topic><topic>Therapeutic target</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Mingli</creatorcontrib><creatorcontrib>Zhou, Xueying</creatorcontrib><creatorcontrib>Jiang, Wei</creatorcontrib><creatorcontrib>Li, Min</creatorcontrib><creatorcontrib>Zhou, Ruijiao</creatorcontrib><creatorcontrib>Zhou, Shengnian</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Mingli</au><au>Zhou, Xueying</au><au>Jiang, Wei</au><au>Li, Min</au><au>Zhou, Ruijiao</au><au>Zhou, Shengnian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AJAP1 affects behavioral changes and GABABR1 level in epileptic mice</atitle><jtitle>Biochemical and biophysical research communications</jtitle><date>2020-04-16</date><risdate>2020</risdate><volume>524</volume><issue>4</issue><spage>1057</spage><epage>1063</epage><pages>1057-1063</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Adherens junction-associated protein-1 (AJAP1), also called SHREW1, was first discovered as a novel component of adherens junctions in 2004. In later studies, AJAP1 was found to suppress invasion and predict recurrence of some tumors. Apart from its function as a putative tumor suppressor, AJAP1 is still poorly understood. Schwenk et al. recently found that AJAP1 was tightly associated with the γ-Aminobutyric acid type B receptor subunit 1(GABABR1). It is well known that GABABR plays a vital role in epilepsy as an inhibitory transmitter receptor. Structurally adjacent, possibly functionally interacting, therefore, we hypothesize that AJAP1 participates in the onset and progression of epilepsy. We designed this experiment to investigate the expression and location of AJAP1 in temporal lobe epilepsy (TLE) patients and kainic acid(KA)-induced epilepsy animal models by immunofluorescence and Western blot analyses. We overexpressed and inhibited AJAP1 through lentiviruses in KA-induced models and observed the corresponding effects on epileptic animals. Double-label immunofluorescence showed that AJAP1 was expressed mainly in neurons. Western blot analysis revealed that AJAP1 expression was downregulated in the neocortex of TLE patients and the hippocampus and neocortex of epileptic animal models. The overexpression of AJAP1 can reduce the frequency of spontaneous seizures, whereas the inhibition of AJAP1 expression can increase the incidence rate. Our study demonstrated that AJAP1 may be involved in the pathogenic process of epilepsy and may represent a novel antiepileptic target. •Our study confirms that AJAP1 is closely related to epilepsy.•The expression of AJAP1 decreased in epileptic patients and animal models.•We have recorded the behavioral changes in epileptic mice with different levels of AJAP1.•We found that epilepsy was negatively correlated with the level of AJAP1.•In epileptic mice, different expression of AJAP1 affects the levels of GABABR1.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.bbrc.2020.02.036</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2020-04, Vol.524 (4), p.1057-1063
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_2357471434
source ScienceDirect Freedom Collection
subjects AJAP1
Epilepsy
GABABR1
Lentivirus
Therapeutic target
title AJAP1 affects behavioral changes and GABABR1 level in epileptic mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T10%3A09%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AJAP1%20affects%20behavioral%20changes%20and%20GABABR1%20level%20in%20epileptic%20mice&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Zhang,%20Mingli&rft.date=2020-04-16&rft.volume=524&rft.issue=4&rft.spage=1057&rft.epage=1063&rft.pages=1057-1063&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2020.02.036&rft_dat=%3Cproquest_cross%3E2357471434%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c333t-2de24e004b3507f899e4c99c7f59271a14b602b1d50b645ec94ccb56556adf043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2357471434&rft_id=info:pmid/&rfr_iscdi=true